Literature DB >> 19057322

Idiopathic subarachnoid hemorrhage and venous drainage: are they related?

José F Alén1, Alfonso Lagares, Jorge Campollo, Federico Ballenilla, Ariel Kaen, Angel P Núñez, Ramiro D Lobato.   

Abstract

OBJECTIVE: In the past, several possible explanations for idiopathic subarachnoid hemorrhage (ISAH) have been proposed; however, neuroimaging studies have never provided conclusive data about the structural cause of the bleeding. The aim of this study is to determine whether there are anatomic differences in the deep cerebral venous drainage in patients with ISAH compared with those with aneurysmal subarachnoid hemorrhage (ASAH) and those without intracranial hemorrhage.
METHODS: We reviewed the venous phase of carotid digital angiograms of 100 consecutive patients who had a final diagnosis of ISAH. We also analyzed the angiograms of a control group of 112 patients with ASAH and the angiograms of a nonhemorrhagic group of 25 patients having incidental aneurysms. The anatomic variants of the basal vein of Rosenthal (BVR) on both sides were classified into the following types: Type A (normal continuous), in which the BVR is continuous with the deep middle cerebral veins and drains mainly into the vein of Galen; Type B (normal discontinuous), in which there is discontinuous venous drainage, anterior to the uncal vein and posterior to the vein of Galen; and Type C (primitive), which drains mainly to veins other than the vein of Galen. We calculated the proportions to analyze the differences in the type of venous drainage between patients with ISAH, patients with ASAH, and patients without hemorrhage. chi2 statistics were used to search for differences.
RESULTS: Types A and C venous drainage were present in 23.8 and 32.3%, respectively, of patients with ISAH compared with 58.7 and 15.4%, respectively, in the ASAH group and 57.5 and 5%, respectively, in the nonhemorrhagic group (P < 0.001). A primitive variant was present in at least 1 hemisphere in 38 patients with ISAH (41.8% of the cases) compared with 24 patients with ASAH (21.4%) and 2 patients (8%) in the nonhemorrhagic group (P < 0.001).
CONCLUSION: In patients with ISAH, deep cerebral venous drainage more commonly drains directly into dural sinuses instead of via the vein of Galen compared with patients with ASAH and patients without intracranial hemorrhage. The way in which this venous configuration might influence bleeding remains unknown.

Entities:  

Mesh:

Year:  2008        PMID: 19057322     DOI: 10.1227/01.NEU.0000335777.14055.71

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Perimesencephalic subarachnoid hemorrhage: when to stop imaging?

Authors:  Juan Pablo Cruz; Dipanka Sarma; Lyne Noel de Tilly
Journal:  Emerg Radiol       Date:  2011-03-01

Review 2.  Nonaneurysmal Perimesencephalic Hemorrhage Is Associated with Deep Cerebral Venous Drainage Anomalies: A Systematic Literature Review and Meta-Analysis.

Authors:  A Rouchaud; V T Lehman; M H Murad; A Burrows; H J Cloft; E P Lindell; D F Kallmes; W Brinjikji
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-12       Impact factor: 3.825

3.  Nonaneurysmal subarachnoid hemorrhage: an update.

Authors:  Young Woo Kim; Matthew F Lawson; Brian L Hoh
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

4.  Familial perimesencephalic subarachnoid hemorrhage: two case reports.

Authors:  Ulaş Cıkla; Beverly Aagaard-Kienitz; Patrick A Turski; Guner Menekse; David B Niemann; Mustafa K Başkaya
Journal:  J Med Case Rep       Date:  2014-11-22

Review 5.  Neural Vascular Mechanism for the Cerebral Blood Flow Autoregulation after Hemorrhagic Stroke.

Authors:  Ming Xiao; Qiang Li; Hua Feng; Le Zhang; Yujie Chen
Journal:  Neural Plast       Date:  2017-09-26       Impact factor: 3.599

6.  Management of Spontaneous Subarachnoid Hemorrhage Patients with Negative Initial Digital Subtraction Angiogram Findings: Conservative or Aggressive?

Authors:  Liang Xu; Yuanjian Fang; Xudan Shi; Xianyi Chen; Jun Yu; Zeyu Sun; Jianmin Zhang; Jing Xu
Journal:  Biomed Res Int       Date:  2017-05-02       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.